One Case of Reversible Posterior Leukoencephalopathy Syndrome Induced by Methotrexate

Abstract

CLC Number:

R994.11

TIAN Jixin, ZHANG Ping, MIAO Wenjuan, LIAO Yingxi, WANG Xiaodan, LI Shan, YAN Haihong. One Case of Reversible Posterior Leukoencephalopathy Syndrome Induced by Methotrexate[J]. Chinese Journal of Pharmacovigilance, 2019, 16(2): 126-128.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2019/V16/I2/126

References

[1] Dufourg M N, Landman-Parker J, Auclerc M F, et a1. Age and high-dose methotrexate are associated to clinical acute encepha-lopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children[J]. Leukemia, 2007, 21(2): 238-247.
[2] 罗学群, 柯志勇, 刘栓梁. 大剂量化疗药致脑毒性三例[J]. 中华血液学杂志, 2004, 25(2): 128.
[3] 徐基昕, 孔令军, 张淑红,等. 甲氨蝶呤治疗儿童急性淋巴细胞白血病致白质脑病二例[J]. 白血病·淋巴瘤, 2016, 25(10): 623-625.
[4] Donmez F Y, Guleryuz P, Agildere M.MRI findings in childhood PRES: What is different than the Adults?[J]. Clin Neuroradiol, 2016, 26(2): 209-213.
[5] Bhojwani D, Sabin N D, Pei D, et a1. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphobla-stic leukemia[J]. J Clin Oncol, 2014, 32(9): 949-959.
[6] Kishi S, Cheng C, French D, et a1. Ancestry and pharmacogenetics of antileukemic drug toxicity[J]. Blood, 2007, 109(10): 4151-4157.
[7] Marra A, Vargas M, Striano P, et a1. Posterior reversible encephalo-pathy syndrome: the endothelial hypotheses[J]. Med Hypotheses, 2014, 82(5): 619-622.
[8] Gümüs H, Per H, Kumandas S, et a1. Reversible posterior leukoen-cephalopathy syndrome in childhood: report of nine cases and review of the literature[J]. Neurol Sci, 2010, 31(2): 125-131.
[9] González-Suárez I, Aguilar-Amat MJ, Trigueros M, et a1. Leukoencephalopathy due to oral methotrexate[J]. Cerebellum, 2014, 13(1): 178-183.
[10] 尤海生, 董亚琳. 甲氨蝶呤鞘内注射致神经系统不良反应分析[J]. 中国医院药学杂志, 2008, 28(16): 1386-1388.
[11] Vezmar S, Becker A, Bode U, et a1. Biochemical and clinical aspects of methotrexate neurotoxicity[J]. Chemotherapy, 2003, 49(1-2): 92-104.
[12] Becker A, Vezmar S, Linnebank M, et a1. Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate[J]. Int J Clin Pharmacol Ther, 2007, 45(9): 504-515.
[13] Vagace J M, Caceres-Marzal C, Jimenez M, et a1. Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis[J]. Am J Hematol, 2011, 86(1): 98-101.

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.